Safety of HIV medications – new podcast out now

In focus / 04 May 2022

Henry Zakumumpa from Makerere University School of Public Health airs his research on HIV care and treatment strategies in Uganda and the need for more robust pharmacovigilance.


With the right care, people infected with HIV can lead long and healthy lives. But as with any life-long medical treatment, it is important to acknowledge and manage any side effects.  

In the latest episode of Drug Safety Matters, Henry Zakumumpa from Makerere University School of Public Health tells podcast host Federica Santoro about the potential harms of new HIV therapies and the challenges faced by pharmacovigilance specialists in Uganda. 

Subscribe by visiting the Drug Safety Matters website or listen in right here:

Related Articles

How diclofenac drove vultures to the brink and unleashed a rabies crisis

Pharmacovigilance as a key tool in the One Health approach to AMR

Orphan Drugs: Hope for rare disease communities

You may also like

Pharmacovigilance as a key tool in the One Health approach to AMR

The One Health approach aims to combat resistant organisms spreading between humans, animals and environments, safeguarding antimicrobials for the future.

21 May 2025

How diclofenac drove vultures to the brink and unleashed a rabies crisis

How one unusual crisis highlights the need to more effectively integrate the One Health approach and ecopharmacovigilance into pharmaceutical monitoring and legislation.

20 August 2025

Orphan Drugs: Hope for rare disease communities

Orphan drug monitoring emerges as a critical lifeline for rare diseases, offering hope to patients with uncommon medical conditions.

14 April 2025